Recruiting Thyroid Cancer Studies in New York
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
This research is being done to evaluate the safety and efficacy of neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC). This resea...
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
The researchers are doing this study to find out if the combination of avutometinib and defactinib is an effective treatment for RAF dimer-driven radioiodine-refractory differentiated thyroid cancer o...
About Thyroid Cancer Clinical Trials in New York
Thyroid cancer develops in the thyroid gland and is the most common endocrine malignancy. Most thyroid cancers are highly treatable with excellent prognosis. Types include papillary, follicular, medullary, and anaplastic thyroid cancer.
There are currently 2 thyroid cancer clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 60 participants. Research is being sponsored by Massachusetts Eye and Ear Infirmary, Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thyroid Cancer Clinical Trials in New York — FAQ
Are there thyroid cancer clinical trials in New York?
Yes, there are 2 thyroid cancer clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What thyroid cancer treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for thyroid cancer.
Data updated March 2, 2026 from ClinicalTrials.gov